We are live on ! Find out more
DG

David Goel Matrix Capital Management Company

AUM $46.3M
1-Year Est. Return 114.38%
 

David Goel is a co-founder of Matrix Capital Management, a technology-oriented investment firm with public and private market activities. Matrix is known for concentrated positions in software, semiconductor, and internet-related businesses. Goel’s filings are monitored for high-conviction technology themes.

This Fund
S&P 500
This Quarter Est. Return
+22.75%
1 Year Est. Return
+114.38%
3 Year Est. Return
+245.06%
5 Year Est. Return
+259.19%
10 Year Est. Return
+1,887.32%
AUM
$46.3M
AUM Growth
-$11.3M
Cap. Flow
-$19.9M
Cap. Flow %
-42.94%
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
–
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
MAZE
Maze Therapeutics
MAZE
+$19.9M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AURA icon
1
Aura Biosciences
AURA
$809M
$46.3M 100%
6,922,870
– –
MAZE
2
Maze Therapeutics
MAZE
$1.63B
– –
-480,000
Closed -$19.9M

Similar funds

RRC
Range Rock Capital Wellesley, Massachusetts $46.7M AUM
IPHI
Inflection Point Holdings II New York $47.3M AUM
HPM
HealthCor Partners Management Charleston, South Carolina $50.7M AUM
SCP
SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM
SPIG
Silversmith Partners I GP Boston, Massachusetts $39.2M AUM
BAM
BLKBRD Asset Management Old Greenwich, Connecticut $38.3M AUM 34.49% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
CM
CoinFund Management New York $35.4M AUM

David Goel's Q1 2026 Portfolio in Review

As of Q1 2026, David Goel held 2 positions worth $46.3M, down 20% from $57.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

David Goel withdrew a net $19.9M in Q1 2026, closing 1 position. Its most notable exit was Maze Therapeutics, an estimated $19.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • David Goel fully exited Maze Therapeutics in Q1 2026, selling an estimated $19.9M.
  • David Goel's ten largest holdings make up 100% of its $46.3M portfolio in Q1 2026.
  • David Goel opened 0 new positions and closed 1 in Q1 2026.
  • David Goel's portfolio value fell 20% quarter-over-quarter to $46.3M.

Based on Matrix Capital Management Company's 13F filing for Q1 2026, filed 14 May 2026.